71
Views
4
CrossRef citations to date
0
Altmetric
LetterToEditor Article

Lack of Prognostic Value of CD34 in Adult AML

, , , , , , & show all
Pages 185-186 | Received 20 Jan 1996, Published online: 01 Jul 2009

References

  • Capos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukemia: Correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol. 1989; 72: 161–166
  • Borowitz M. J., Gockerman J. P., Moore J. O., Civin C. I., Page S. O., Robertson J., Bigner S. H. Clinicopathological and cytogenetic features of CD34 (MY10) positive acute nonlymphoblastic leukemia. Am. J. Clin. Pathol. 1989; 91: 265–270
  • Geller R. B., Zahurak M., Hurwitz C. A., Burke J. P., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myeloblastic leukemia. The significance of the stem cell glycoprotein CD34 (MY10). Br. J. Haematol. 1990; 76: 340–347
  • Sperling C., BÜChner T., Creutzig U., Ritter J., Harbott J., Fonatsch C., Sauerland C., Mielcarek M., Maschmeyer G., Loffler H., Ludwig W. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood adult de novo AML. Leuk. Lymphoma 1995; 17: 417–426

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.